Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

Yael L. Maxwell

June 17, 2024

News Daily News

Differences Across AUC Documents Sow Confusion for CAD Imaging

Shelley Wood

August 22, 2023

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2019

Shelley Wood

December 31, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Presentation TCT 2018

CHIP in The Diabetic Patient: Special Considerations

Presenter: David J. Maron, Steven P. Marso, Cindy L. Grines

September 22, 2018

Presentation TCT 2018

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

Presenter: David J. Maron, Steven P. Marso, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Presenter: David J. Maron, Steven P. Marso, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Presenter: David J. Maron, Steven P. Marso, Norman E. Lepor

September 22, 2018

Presentation TCT 2018

Comprehensive CV Risk Reduction Strategy in Diabetics

Presenter: David J. Maron, Steven P. Marso, Kurt Huber

September 22, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

Presentation TCT 2017

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Advertisement

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

Differences Across AUC Documents Sow Confusion for CAD Imaging

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

TCTMD’s Top 10 Most Popular Stories for December 2019

ISCHEMIA Questions? Some Answers From David Maron

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

CHIP in The Diabetic Patient: Special Considerations

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Comprehensive CV Risk Reduction Strategy in Diabetics

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content